We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$104B
AUM Growth
+$6.58B
Cap. Flow
-$453M
Cap. Flow %
-0.43%
Top 10 Hldgs %
10.66%
Holding
2,865
New
128
Increased
1,119
Reduced
1,402
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Industrials 13.85%
3 Financials 12.11%
4 Consumer Discretionary 11.36%
5 Healthcare 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNKD icon
2501
MannKind Corp
MNKD
$1.32B
$199K ﹤0.01%
36,512
-824
-2% -$3.57K
ESCA icon
2502
Escalade
ESCA
$311M
$196K ﹤0.01%
8,557
+3,457
+68% +$79.2K
PBF icon
2503
PBF Energy
PBF
$7.31B
$194K ﹤0.01%
12,688
-581
-4% -$8.97K
ATRA icon
2504
Atara Biotherapeutics
ATRA
$76.1M
$192K ﹤0.01%
493
-12
-2% -$4.28K
NEXI
2505
DELISTED
NexImmune, Inc. Common Stock
NEXI
$192K ﹤0.01%
471
+29
+7% +$13.4K
HMHC
2506
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$191K ﹤0.01%
17,266
-356
-2% -$3.35K
ARRY icon
2507
Array Technologies
ARRY
$855M
$190K ﹤0.01%
12,207
-24,273
-67% -$512K
SENS icon
2508
Senseonics Holdings Inc
SENS
$366M
$189K ﹤0.01%
2,462
+344
+16% +$17.4K
ATEC icon
2509
Alphatec Holdings
ATEC
$1.44B
$188K ﹤0.01%
12,287
-1,935
-14% -$29.8K
AXTI icon
2510
AXT Inc
AXTI
$5.8B
$188K ﹤0.01%
17,095
+4,384
+34% +$46.5K
BOLT icon
2511
Bolt Biotherapeutics
BOLT
$7.78M
$188K ﹤0.01%
608
+16
+3% +$6.5K
OII icon
2512
Oceaneering
OII
$4.77B
$188K ﹤0.01%
12,103
+2
+0% +$28
LBRT icon
2513
Liberty Energy
LBRT
$3.25B
$185K ﹤0.01%
13,059
-359
-3% -$4.84K
CBAY
2514
DELISTED
Cymabay Therapeutics
CBAY
$185K ﹤0.01%
42,448
-27,994
-40% -$124K
HOFT icon
2515
Hooker Furnishings Corp
HOFT
$166M
$183K ﹤0.01%
5,272
-2,968
-36% -$111K
NMFC icon
2516
New Mountain Finance
NMFC
$732M
$183K ﹤0.01%
13,884
-431
-3% -$5.63K
IMGN
2517
DELISTED
Immunogen Inc
IMGN
$183K ﹤0.01%
27,725
-2,446
-8% -$17.1K
UFPT icon
2518
UFP Technologies
UFPT
$2.43B
$180K ﹤0.01%
3,130
NUVB.WS
2519
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$179K ﹤0.01%
68,951
GPRO icon
2520
GoPro
GPRO
$126M
$177K ﹤0.01%
15,224
-531
-3% -$5.99K
CENT icon
2521
Central Garden & Pet Co
CENT
$2.8B
$169K ﹤0.01%
+3,988
New +$179K
OCSL icon
2522
Oaktree Specialty Lending
OCSL
$1.14B
$165K ﹤0.01%
8,242
-548
-6% -$11K
AROC icon
2523
Archrock
AROC
$5.8B
$162K ﹤0.01%
18,207
-650
-3% -$6.07K
AGEN
2524
Agenus
AGEN
$290M
$160K ﹤0.01%
1,482
+128
+9% +$9.6K
IRMD icon
2525
iRadimed
IRMD
$1.18B
$160K ﹤0.01%
5,452
+222
+4% +$6.12K

Similar funds

Victory Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Victory Capital Management held 2,865 positions worth $104B, up 6.7% from $97.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q2 2021 filing shows 128 new, 1,119 increased, 1,402 reduced and 129 closed positions. Its largest new stake was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M. The largest sale was Darden Restaurants, an estimated $302M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q2 2021 buy was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M.
  • Victory Capital Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $1.28B increase.
  • Victory Capital Management's biggest Q2 2021 reduction was Darden Restaurants, cutting an estimated $302M.
  • Victory Capital Management fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $245M.
  • Victory Capital Management's ten largest holdings make up 11% of its $104B portfolio in Q2 2021.
  • Victory Capital Management opened 128 new positions and closed 129 in Q2 2021.
  • Victory Capital Management's portfolio value rose 6.7% quarter-over-quarter to $104B.

Based on Victory Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.